NCT00455897 2018-01-18
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Massachusetts General Hospital
Phase 2 Terminated
Clinical Trials
1 trialsTerminated × Lymphoma, Large B-Cell, Diffuse × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all